Giuseppe Giaccone

Giuseppe Giacone (; 9 September 1900 – 6 May 1986) was an Italian footballer who played as a goalkeeper. He competed in the men's tournament at the 1920 Summer Olympics. He was the first Juventus player to play for the Italy national team when he played on 28 March 1920 in a friendly match; a 3–0 away loss against Switzerland. Provided by Wikipedia
Showing 1 - 20 results of 21 for search 'Giuseppe Giaccone', query time: 0.06s Refine Results
  1. 1
    In Memory of Professor John Gordon McVie: Bringing People Together 13 January 1945 – 20 January 2021

    In Memory of Professor John Gordon McVie: Bringing People Together 13 January 1945 – 20 January 2021 by Giuseppe Giaccone

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology

    Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology by Wafik S. El-Deiry, Giuseppe Giaccone

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Molecular predictors of response to pembrolizumab in thymic carcinoma

    Molecular predictors of response to pembrolizumab in thymic carcinoma by Yongfeng He, Archana Ramesh, Yuriy Gusev, Krithika Bhuvaneshwar, Giuseppe Giaccone

    Published 2021-09-01
    Get full text
    Article
  4. 4
    A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

    A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer by Chul Kim, Stephen V. Liu, Jennifer Crawford, Tisdrey Torres, Vincent Chen, Jillian Thompson, Ming Tan, Giuseppe Esposito, Deepa S. Subramaniam, Deepa S. Subramaniam, Giuseppe Giaccone, Giuseppe Giaccone

    Published 2021-09-01
    Get full text
    Article
  5. 5
    A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer

    A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer by Deepa S. Subramaniam, Stephen V. Liu, Jeanette Crawford, Jenna Kramer, Jillian Thompson, Hongkun Wang, Giuseppe Giaccone

    Published 2018-03-01
    Get full text
    Article
  6. 6
    Whole genome and transcriptome sequencing of a B3 thymoma.

    Whole genome and transcriptome sequencing of a B3 thymoma. by Iacopo Petrini, Arun Rajan, Trung Pham, Donna Voeller, Sean Davis, James Gao, Yisong Wang, Giuseppe Giaccone

    Published 2013-01-01
    Get full text
    Article
  7. 7
    MicroRNA expression and clinical outcome of small cell lung cancer.

    MicroRNA expression and clinical outcome of small cell lung cancer. by Jih-Hsiang Lee, Johannes Voortman, Anne-Marie C Dingemans, Donna M Voeller, Trung Pham, Yisong Wang, Giuseppe Giaccone

    Published 2011-01-01
    Get full text
    Article
  8. 8
    Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.

    Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer. by Tristan M Sissung, Arun Rajan, Gideon M Blumenthal, David J Liewehr, Seth M Steinberg, Arlene Berman, Giuseppe Giaccone, William D Figg

    Published 2019-01-01
    Get full text
    Article
  9. 9
    Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations

    Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations by Guanhua Rao, Mariaelena Pierobon, In-Kyu Kim, Wei-Hsun Hsu, Jianghong Deng, Yong-Wha Moon, Emanuel F. Petricoin, Yu-Wen Zhang, Yisong Wang, Giuseppe Giaccone

    Published 2017-08-01
    Get full text
    Article
  10. 10
    The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm

    The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm by Hua Zhang, Wuhao Huang, Chang Liu, Giuseppe Giaccone, Xiaoliang Zhao, Xiaoyan Sun, Jingjing Li, Runfen Cheng, Qiujuan Huang, Huilan Mo, Zhenfa Zhang, Bin Zhang, Changli Wang

    Published 2021-05-01
    Get full text
    Article
  11. 11
    Cardiomyocyte-Specific Circulating Cell-Free Methylated DNA in Esophageal Cancer Patients Treated with Chemoradiation

    Cardiomyocyte-Specific Circulating Cell-Free Methylated DNA in Esophageal Cancer Patients Treated with Chemoradiation by Sarah Martinez Roth, Eveline E. Vietsch, Megan E. Barefoot, Marcel O. Schmidt, Matthew D. Park, Archana Ramesh, Michael R. Lindberg, Giuseppe Giaccone, Anna T. Riegel, Ana Barac, Keith Unger, Anton Wellstein

    Published 2021-07-01
    Get full text
    Article
  12. 12
    Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation

    Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation by Xiaoliang Zhao, In‐Kyu Kim, Bhaskar Kallakury, Joeffrey J. Chahine, Eiji Iwama, Mariaelena Pierobon, Emanuel Petricoin, Justine N. McCutcheon, Yu‐Wen Zhang, Shigeki Umemura, Vincent Chen, Changli Wang, Giuseppe Giaccone

    Published 2021-04-01
    Get full text
    Article
  13. 13
    Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.

    Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. by Mariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, José A Rodriguez, Gerrit A Meijer, Wolter J Mooi, Ewa Jassem, Jacek Niklinski, Thomas Muley, Nico van Zandwijk, Egbert F Smit, Kristin Beebe, Len Neckers, Bauke Ylstra, Giuseppe Giaccone

    Published 2008-03-01
    Get full text
    Article
  14. 14
    Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

    Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis by Isabella Sala, Isabella Sala, Eleonora Pagan, Laura Pala, Chiara Oriecuia, Chiara Oriecuia, Marco Musca, Marco Musca, Claudia Specchia, Tommaso De Pas, Javier Cortes, Javier Cortes, Javier Cortes, Giuseppe Giaccone, Michael Postow, Richard D. Gelber, Vincenzo Bagnardi, Fabio Conforti, Fabio Conforti

    Published 2024-01-01
    Get full text
    Article
  15. 15
    High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy

    High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy by Michael Carrasquilla, MD, Nitika Paudel, MD, PhD, Brian T. Collins, MD, Eric Anderson, MD, Rebecca Krochmal, MD, Marc Margolis, MD, Ahssan Balawi, MS, CMD, David DeBlois, BS, CMD, Giuseppe Giaccone, MD, PhD, Chul Kim, MD, Stephen Liu, MD, Jonathan W. Lischalk, MD

    Published 2023-03-01
    Get full text
    Article
  16. 16
    Image microarrays (IMA): Digital pathology′s missing tool

    Image microarrays (IMA): Digital pathology′s missing tool by Jason Hipp, Jerome Cheng, Liron Pantanowitz, Stephen Hewitt, Yukako Yagi, James Monaco, Anant Madabhushi, Jaime Rodriguez-canales, Jeffrey Hanson, Sinchita Roy-Chowdhuri, Armando C Filie, Michael D Feldman, John E Tomaszewski, Natalie NC Shih, Victor Brodsky, Giuseppe Giaccone, Michael R Emmert-Buck, Ulysses J Balis

    Published 2011-01-01
    Get full text
    Article
  17. 17
    American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

    American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer by Giuseppe GIACCONE, David TRENT, John R. STRAWN, Reily SMITH, Thomas J. SMITH, Joan H. SCHILLER, David G. PFISTER, Steven PIANTADOSI, Luke NORDQUIST, Daniel MILTON, Gregory MASTERS, Janessa L. LASKI, David H. JOHNSON, Julie BRAHMER, William PAO, Timothy ALIFF, Sarah TEMIN, Sherman Baker JR, Christopher G. AZZOLI

    Published 2010-03-01
    Get full text
    Article
  18. 18
    606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy

    606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy by Robert Johnston, Hartmut Koeppen, Roy S Herbst, Kurt Schalper, Filippo De Marinis, Giuseppe Giaccone, Jacek Jassem, Marcus Ballinger, Barani Kumar Rajendran, David R Spigel, Miguel López de Rodas, Minu K Srivastava, Jennifer M Giltnane, Barzin Y Nabet, David S Shames, Velimir Gayevskiy, Vy Ma, Ivette Estay, Tien Hoang, Reena Amin

    Published 2023-11-01
    Article
  19. 19
    Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities

    Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities by Yosuke Yamada, Djeda Belharazem-Vitacolonnna, Hanibal Bohnenberger, Christel Weiß, Naoko Matsui, Mark Kriegsmann, Katharina Kriegsmann, Peter Sinn, Katja Simon-Keller, Gerhard Hamilton, Thomas Graeter, Gerhard Preissler, German Ott, Sebastian Schölch, Naoki Nakajima, Akihiko Yoshizawa, Hironori Haga, Hiroshi Date, Roman K. Thomas, Iacopo Petrini, Giuseppe Giaccone, Philipp Ströbel, Alexander Marx

    Published 2022-11-01
    Get full text
    Article
  20. 20
    Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.

    Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC. by Michael E Goldberg, Meagan Montesion, Lauren Young, James Suh, Joel Greenbowe, Mark Kennedy, Giuseppe Giaccone, Wallace L Akerley, Afshin Dowlati, Benjamin C Creelan, James K Hicks, Paul J Hesketh, Karen L Kelly, Jonathan W Riess, Vincent A Miller, Philip J Stephens, Garrett M Frampton, Siraj Ali, Jeffrey P Gregg, Lee A Albacker

    Published 2018-01-01
    Get full text
    Article

Search Tools: